There has been a renewal of interest in recent years in the pathogenesis of antibody-mediated red cell destruction. Most of the experimental work has been done with alloantibodies, but assumedly autoantibodies lead to red cell destruction in a similar manner. This paper attempts to correlate the results of these experiments with the findings in patients with positive antiglobulin tests and autoimmune haemolytic anaemia (AIHA).
Known and speculative methods of red cell destruction LYSIS BY COMPLEMENT One molecule of IgM antibody bound to the red cell surface is theoretically able to activate the whole of the complement sequence and lead to lysis of the red cell. Two molecules of IgG close together on the cell membrane are needed to start the same sequence. Most IgM red cell antibodies will bind at least some of the components of complement (although there are important exceptions) while, of the others, only IgGl and IgG3 bind complement readily. For lysis to occur active C8 must enter the preformed channels on the cell surface formed by C5-7 and damage the membrane. C9 catalyses this process (MullerEberhard, 1975) .
If membranes lysed by complement are examined with an electron microscope 'holes' will be seen (Humphrey and Dourmashkin, 1965) . With human complement these are about 100 nm in diameter regardless of whether the complement was fixed by antibody or not and regardless of the specificity of the antibody. This size is too small for haemoglobin to escape and consequently water and ions are drawn into the red cell until it bursts (Rosse et al., 1966) .
Probably all antibodies in the ABO, Lewis, P, or J systems are potentially lytic but the number that cause marked haemolysis in vitro is relatively small. Rare antibodies such as anti-Vel are often lytic, and very occasional examples of anti-Jka and anti-Dia will lyse red cells that have not been treated with enzymes. If radiolabelled B or A red cells are given to a volunteer with a potent lytic anti-A or B in the plasma they disappear from the circulation within a few minutes, haemoglobin will be seen in the plasma and, if sufficient, in the urine, and very little radioactivity will appear in the liver or spleen on scanning (Jandl et al., 1957 (Rowlands and Daniele, 1975) . These cells are not phagocytic and are not thought, as yet, to have any role in red cell destruction. The function of the neutrophil receptor is also not entirely known, and it seems that monocytes and macrophages are the more important cells in red cell destruction.
This complement receptor seems to differ from the IgG receptor (which will be mentioned later) but it is interesting that the latter is specific for IgG1 and IgG3, the two subclasses of IgG that fix complement most easily. When red cells are sensitised with IgGI and/or IgG3 antibody and complement the two receptors appear to work together synergistically (Bianco et al., 1975) . The complement receptor is specific for active C3, C3b (Huber et al., 1968) . Active C42 (C3 convertase) splits the native C3 molecule into C3a and C3b. The C3b can attach to red cell surfaces, and these coated cells can adhere to macrophages and perhaps be phagocytosed by them. The life-span of C3b, however, is short. C3b inactivator is present in the plasma and this, with other enzymes, splits C3b into C3c and C3d (MullerEberhard, 1975) . The C3d remains attached to the red cell and when this happens the coated cell no longer adheres to the macrophage and can return to the circulation (Brown, 1974) . The B lymphocytes that have C3b receptors may also have different receptors that are specific for C3d. Their function is unknown and, again, they do not seem to play any part in red cell destruction (Ross and Polley, 1975) .
Macrophages with C3b receptors are distributed throughout the reticuloendothelial system (RES). Native C3 does not compete for these receptors and 90 therefore the adherence of C3b-coated red cells is not inhibited by plasma. If such cells are labelled and injected into animals they disappear immediately and, on scanning, the liver, because of its greater blood supply, appears to be the major organ of sequestration (Brown et al., 1970) . Whether the labelled red cells reappear subsequently in the circulation depends to a large extent on how the C3b was bound.
If only complement is bound to the red cells and precautions are taken to ensure that lysis does not occur the coated cells will reappear in the circulation and their subsequent survival may well be normal (Brown et al., 1970 (Brown et al., 1970; Atkinson and Frank, 1974a) . Seemingly macrophages have no receptor for IgM, but if the IgM coating on the red cells is heavy direct agglutination will occur. It is difficult to imagine that this will be completely harmless (see later).
Most blood group antibodies bind some of the components of complement but antibodies in the Rh system, even if IgM, are the most important among those that do not usually bind complement at all. This may be explained by the distribution of the antigen sites, which are widely dispersed and tend to be single (Nicolson et al., 1971) . Perhaps they are too distant for at least two antigen-binding sites on one IgM molecule to combine with the antigen, which must occur before complement can be activated (Ishizaka et al., 1968) . However, Rosse (1968) suggested that when several IgG antibodies with different Rh specificities were all combined at once with the red cell at least CT could be fixed.
When IgG antibody binds complement the destruction of coated red cells is complicated by the presence of IgG receptors on the macrophage.
MACROPHAGE AND MONOCYTE RECEPTORS

FOR IgG
These receptors are also present on neutrophils although there is some evidence that they may be less numerous than on monocytes (Messner and Jelinek, 1970) . They appear to react only with the Fc portion of IgGI and IgG3 (Huber et al., 1971) . There is competition between IgGl and IgG3 in the plasma and IgGl-and IgG3-coated red cells. According to Huber et al. (1971) there is only one receptor for IgG and the adherence of IgG1-coated red cells can be inhibited by pure IgG3 in the surrounding medium and vice versa. In fact this competition by plasma is so great that it is difficult to imagine how this adherence could occur at all in vivo: red cells lightly coated with IgG anti-D, which, nevertheless, would disappear rapidly in vivo, are inhibited from binding to macrophages by a concentration of IgG one thousandth of that which occurs in normal plasma (Mollison, 1978) . When LoBuglio and his colleagues first showed in 1967 that these receptors were present they suggested that this competition with the plasma might be overcome in vivo by concentration of red cells and reduction of the plasma in the red pulp of the spleen. Here the sensitised red cells would be forced into close proximity with the macrophage and adherence might occur. In the rest of the RES the macrophages would be bathed in plasma and adherence would be inhibited.
When the adherence of either IgG-or C3b-coated red cells to monocytes is examined in stained films the red cells are seen to form rosettes around the monocytes. If the interface between the monocyte and red cells is looked at with an electron microscope outgrowths of the monocyte distorting and interdigitating with the red cell membrane are seen (Brown and Nelson, 1973) . The contact is a powerful local stimulus to pinocytosis and phagocytosis (at least with red cells coated with suitable IgG or heavily coated with complement). Enzymes released from the lysosomes of monocytes probably damage the red cell membrane (Fleer et al., 1978) . These damaged red cells try to reseal and their loss of surface without loss of contents leads to spherocytosis. The phagocytic stimulus can be shown to be localised and not generalised because the macrophage membranes will ingest particles coated with whole antibody while failing to ingest other particles adjacent to them and only coated with F(ab)2 (Griffin and Silverstein, 1974) . Cells coated with C3b without IgG do not seem to be readily phagocytosed although they adhere to monocytes rapidly: cells coated with IgG, although they adhere less easily, are rapidly phagocytosed once they have adhered. Brown (1974) has suggested that this difference between IgG and C3b is more apparent than real and may depend on the localisation of the stimulus on the red cell membrane. IgG-coated red cells are likely to have antibody widely distributed over the red cell membrane: C3b-coated red cells are likely to have the C3b deposited in clusters around C42. Certainly Brown and Nelson (1973) (Perlmann and Holm, 1969) . Urbaniak (1976) showed that lymphocytes would lyse Rh-coated red cells in the presence of concentrations of IgG that would inhibit monocyte destruction completely. But other workers do not agree (Poplack et al., 1976) and the results need confirmation. Moreover, the red cells were pretreated with papain and thus were not completely normal.
Whether there is some other method of red cell destruction is not at all clear. It would seem from the evidence of patients that there must be. What it is is unknown.
Evidence from patients with a positive direct antiglobulin test and AIHA
LYSIS BY COMPLEMENT
Haemolytic is perhaps a bad term for the increased red cell destruction of AIHA. The uninitiated might think that this was always due to intravascular haemolysis by complement. Paroxysmal cold haemoglobulinuria (PCH), the rarest of the AIHAs (Table  1) , is the only one in which intravascular haemolysis surface (Dacie and Worlledge, 1969) . Most of these patients showed no evidence of increased red cell destruction. When this complement was analysed further it was found to be C3d and/or C4d. What this coating means is not known. Many of the patients were suffering from infections, some had other evidence of 'autoimmune' disorders. It has been shown that cells coated with C3d and/or C4d may survive normally (Mollison, 1965) .
A minority of the patients classified as 'warm' AIHA (9 of the total; (Table 2) . How this complement is bound is not at all clear because it is not usually possible to show that the eluted IgG antibody will bind any complement. The IgG autoantibody of most patients (about two-thirds) with non-drug-induced warm AIHA shows 'Rh' specificity: the remainder show 'Ena' or 'Wrb' specificity or a 'non-specific' antibody, or a mixture of these with 'Rh' specificity. It is commoner to find complement as well as IgG on the red cells of patients with autoantibodies in the second category than it is to find it on the red cells of patients with autoantibodies with 'pure' 'Rh' specificity (Table 3) . Patients with a positive direct antiglobulin test or AIHA due to methyldopa, who all have autoantibodies with 'Rh' specificity, never show any complement on their red cells. Patients suffering from cold haemagglutinin disease (CHAD) show only complement on their red cells if these are washed at 37°C, which they must be in order to get red cells unagglutinated in saline.
Further tests show that these cells are coated only with C3d and C4d. Patients with the chronic form of the disease seldom have haemoglobinuria, although the fact that the antibody is potentially lytic can be seen from the constant haemosiderinuria and low total serum complement that is characteristic of the disease. C3d is a non-haemolytic end-stage of the complement sequence and means that further components cannot be bound: this probably protects the red cells from haemolysis. Evans et al. (1968) showed that when radiolabelled normal red cells were transfused to such patients about half were destroyed at once, but when the same cells had been pretreated with anti-I and sublytic doses of complement the Table 4 Number ofpatients who had IgG on their red cells related to the reactions of their red cells with subclass antisera, to whether they showed overt haemolysis at the time of the tests, and to whether complement was present in addition to IgG nucleosis. This, presumably, is due to the rapid increase in complement binding autoantibody in a patient with normal complement levels. In both the transient and chronic forms of the disorder the antibody is, in our experience, nearly always IgM and has specificity withln the I/i system. Cell survival studies using normal red cells show that these are rapidly sequestered, a proportion are destroyed immediately, and the remainder reappear in the circulation with a variable life-span, often nearly normal. Scanning studies show the majority of the radioactivity appears in the liver and thus splenectomy would not be beneficial.
MACROPHAGE AND MONOCYTE RECEPTORS FOR IgG
Most patients with warm AIHA have some IgG on their red cells (Table 2 ). When this is tested with subclass antisera the majority are found to have at least IgGI (Table 4) . However, Table 4 shows that patients with IgGI on the red cell surface do not necessarily suffer from overt haemolysis even though the red cells also react strongly with anti-complement. Patients with IgG3 on the red cell surface always show overt haemolysis if the spleen is intact.
Experimental work has shown that the macrophage does not have receptors for IgA, although Abramson and Schur (1972) showed that when IgG was present as well IgA seemed to enhance its adherence to the IgG receptor. Occasionally patients appear to have only IgA on their red cells (Table 2 ). These present in a manner similar to those with only IgG on their red cells, and if survival and scanning studies are done the spleen is seen to be the major organ of red cell destruction. They usually respond well to prednisolone and will benefit from splenectomy. How these red cells are destroyed is unknown. If there is a different mechanism for them it may well apply to IgG-coated cells as well.
Spherocytosis is pronounced in the blood films from patients with 'warm' AIHA. It is not characteristic of the blood films from patients with CHAD even though these are made at 37°C to prevent agglutination. It is often seen at the time of haemolysis in PCH. Spherocytosis is also seen when the disorder is caused by alloantibodies, as in transfusion reactions. It is characteristically present in ABO haemolytic disease of the newborn (HDN) but is not usually seen in Rh HDN. It has been known for some time that erythrophagocytosis can be seen in the peripheral blood after transfusion reactions due to antibodies that bind complement (Hopkins, 1910; Ottenberg, 1911 (Atkinson and Frank, 1974b; Schreiber et al., 1975) . In the long term the drug may also lead to a reduction in the amount of autoantibody produced. Prednisolone may be effective not only in 'warm' AIHA but also in chronic CHAD in an acute crisis. However, it is dangerous to use this drug for prolonged treatment in these elderly patients, so it is not generally advocated.
Most of the observed results fit well with the experimental data but there are some obvious discrepancies. One such discrepancy, the mechanism of destruction of IgA-coated red cells, has already been discussed. Other obvious ones are the patients with strongly positive direct antiglobulin tests due to methyldopa, almost always due to IgGI, who have little or no haemolysis, and the patients suffering from Coombs-negative AIHA who have little or no detectable antibody on their red cells and yet have overt haemolysis. The specificity of the antibody might explain some of these cases. The autoantibody in patients taking methyldopa always has 'Rh' specificity, and when an autoantibody can be demonstrated in Coombs-negative AIHA it never, in our experience, shows 'Rh' specificity.
Summary of mechanisms of destruction in AIHA
The mechanism of red cell destruction in PCH is complement-induced intravascular haemolysis. This disorder is often associated with a virus-like illness and sometimes used to be associated with longstanding syphilis, especially congenital syphilis. The condition usually needs no treatment except perhaps blood transfusion if the haemolysis has been unusually severe. The antibody is generally transient and disappears within three months, although in congenital syphilis it disappears only when penicillin is given.
The mechanism of red cell destruction in CHAD is a balance between complement-induced intravascular haemolysis and complement-induced sequestration and phagocytosis. In chronic cases the intravascular haemolysis is limited by deficiency of complement components and the presence of C3d on the red cell surface. Many of the sequestered cells return to circulation with a nearly normal survival and the haemolytic anaemia is usually mild.
The mechanism of red cell destruction in 'warm' AIHA is not fully known. The 
